Generalized Epilepsy
Neurology·MeSH: Epilepsy
3 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| levetiracetam | Mylan II B.V. (MYL) |
Phase 3(1)
| Drug | Company |
|---|---|
| rns system | Neuropace Inc. (NPCE) |
Phase 1(1)
| Drug | Company |
|---|---|
| BHV-7000 | Biohaven Ltd. (BHVN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Generalized Epilepsy?
BioSniper tracks 3 drugs in development for Generalized Epilepsy across 3 companies.
How many clinical trials target Generalized Epilepsy?
There are 1 clinical trial targeting Generalized Epilepsy tracked by BioSniper.
Deep-dive into Generalized Epilepsy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis